Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences, Inc.    GILD

GILEAD SCIENCES, INC.

(GILD)
  Report
Delayed Quote. Delayed Nasdaq - 10/30 04:00:00 pm
58.15 USD   -0.65%
10/29GLOBAL MARKETS LIVE: Big names today
10/29GILEAD SCIENCES : Announces Fourth Quarter 2020 Dividend
AQ
10/29GILEAD SCIENCES : Announces Third Quarter 2020 Financial Results
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 93 58180 91682 20972 904--
Entreprise Value (EV)1 119 53578 44982 45092 67287 79084 289
P/E ratio 20,4x15,0x15,4x107x10,3x9,92x
Yield 2,90%3,65%3,88%4,63%4,84%5,12%
Capitalization / Revenue 3,58x3,66x3,66x3,08x3,04x3,07x
EV / Revenue 4,58x3,55x3,67x3,91x3,66x3,55x
EV / EBITDA 6,90x6,11x6,61x7,27x6,87x6,95x
Price to Book 4,57x3,75x3,65x3,79x3,31x2,97x
Nbr of stocks (in thousands) 1 306 2691 293 6201 265 1461 253 724--
Reference price (USD) 71,662,665,058,258,258,2
Last update 02/06/201802/04/201902/04/202010/29/202010/29/202010/29/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 26 10722 12722 44923 69024 00223 726
EBITDA1 17 31712 84012 46812 75612 77512 124
Operating profit (EBIT)1 16 03111 41111 06411 23511 44711 136
Operating Margin 61,4%51,6%49,3%47,4%47,7%46,9%
Pre-Tax Profit (EBT)1 13 5297 7995 1602 0008 9259 319
Net income1 4 6285 4555 3864247 2356 976
Net margin 17,7%24,7%24,0%1,79%30,1%29,4%
EPS2 3,514,174,220,545,665,86
Dividend per Share2 2,082,282,522,692,822,98
Last update 02/06/201802/04/201902/04/202010/30/202010/30/202010/30/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 25 954-24119 76814 88611 385
Net Cash position1 -2 467----
Leverage (Debt / EBITDA) 1,50x-0,19x0,02x1,55x1,17x0,94x
Free Cash Flow1 11 3087 4768 3197 0539 4929 260
ROE (Net Profit / Equities) 58,5%41,5%38,3%28,6%28,7%27,0%
Shareholders' equity1 7 91513 13614 0551 48125 23725 793
ROA (Net Profit / Asset) 18,3%8,14%8,60%6,89%10,4%10,2%
Assets1 25 26966 97962 6516 14969 29368 301
Book Value Per Share2 15,716,717,815,317,519,6
Cash Flow per Share2 9,026,427,167,706,927,54
Capex1 590924825873792781
Capex / Sales 2,26%4,18%3,67%3,68%3,30%3,29%
Last update 02/06/201802/04/201902/04/202010/29/202010/29/202010/29/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
72 904 072 115
Net sales (USD)
22 449 000 000
Number of employees
11 800
Sales / Employee (USD)
1 902 458
Free-Float
99,7%
Free-Float capitalization (USD)
72 658 396 098
Avg. Exchange 20 sessions (USD)
665 756 893
Average Daily Capital Traded
0,91%
EPS & Dividend